Response by Garcia-Granja et al to Letter Regarding Article, "Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?"

被引:0
|
作者
Elpidio Garcia-Granja, Pablo [1 ]
Sandin-Fuentes, Maria
Garcia-Moran, Emilio
Sevilla, Teresa
Rubio, Jeronimo
机构
[1] Inst Ciencias Corazon, Valladolid, Spain
关键词
ATRIAL-FIBRILLATION;
D O I
10.1161/CIRCULATIONAHA.117.032057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1541 / 1542
页数:2
相关论文
共 50 条
  • [1] Worsening Conduction Delay in Hypertrophic Cardiomyopathy What Drug Is Responsible?
    Elpidio Garcia-Granja, Pablo
    Sandin-Fuentes, Maria
    Garcia-Moran, Emilio
    Sevilla, Teresa
    Rubio, Jeronimo
    CIRCULATION, 2017, 136 (06) : 599 - 601
  • [2] Letter by Jin-shan and Xue-bin Regarding Article, "Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?"
    He Jin-shan
    Li Xue-bin
    CIRCULATION, 2018, 137 (14) : 1540 - 1540
  • [3] Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy"
    Rowin, Ethan J.
    Maron, Martin S.
    Maron, Barry J.
    CIRCULATION, 2018, 137 (23) : 2541 - 2542
  • [4] Letter by Dalzell et al Regarding Article, "Peripartum Cardiomyopathy"
    Dalzell, Jonathan R.
    Barton, Anna K.
    McKeag, Nicholas A.
    CIRCULATION, 2016, 134 (07) : E81 - E82
  • [5] Letter by Puntmann et al Regarding Article, "Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy"
    Puntmann, Valentina O.
    Jansen, Christian
    Nagel, Eike
    CIRCULATION-CARDIOVASCULAR IMAGING, 2012, 5 (05) : E66 - E66
  • [6] Response by Nguyen et al to Letter Regarding Article, "Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients with Hypertrophic Cardiomyopathy"
    Nguyen, Anita
    Schaff, Hartzell V.
    Nishimura, Rick A.
    Dearani, Joseph A.
    Ommen, Steve R.
    CIRCULATION, 2018, 137 (21) : 2303 - 2304
  • [7] Response by Mital et al to Letter Regarding Article, "A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy"
    Mital, Seema
    Armstrong, Katey R.
    Butts, Ryan J.
    Conway, Jennifer
    Fan, Steve
    Gardin, Letizia
    Kantor, Paul F.
    Kaufman, Beth
    Lafreniere-Roula, Myriam
    Miron, Anastasia
    Richmond, Marc E.
    Rossano, Joseph W.
    Russell, Mark W.
    Villa, Chet
    Weintraub, Robert G.
    CIRCULATION, 2021, 143 (11) : E788 - E789
  • [8] Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)"
    Ho, Carolyn Y.
    Day, Sharlene M.
    Ashley, Euan A.
    Michels, Michelle
    Pereira, Alexandre C.
    Jacoby, Daniel
    Lakdawala, Neal K.
    Ware, James S.
    Helms, Adam S.
    Colan, Steven D.
    Seidman, Christine E.
    Olivotto, Iacopo
    CIRCULATION, 2019, 139 (12) : 1559 - 1560
  • [9] Letter by Geier et al regarding article, "Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction"
    Geier, Christian
    Perrot, Andreas
    Oezcelik, Cemil
    CIRCULATION, 2007, 115 (23) : E622 - E622
  • [10] Letter by Ferreira et al Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy"
    Ferreira, Antonio
    Marques, Hugo
    Cardim, Nuno
    CIRCULATION, 2016, 133 (09) : E421 - E421